SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-020127
Filing Date
2022-05-13
Accepted
2022-05-13 16:14:31
Documents
12
Period of Report
2022-05-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K 05132022 alks-8k_20220513.htm   iXBRL 8-K 38303
  Complete submission text file 0001564590-22-020127.txt   166954

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alks-20220513.xsd EX-101.SCH 5589
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE alks-20220513_lab.xml EX-101.LAB 19252
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alks-20220513_pre.xml EX-101.PRE 11462
6 EXTRACTED XBRL INSTANCE DOCUMENT alks-8k_20220513_htm.xml XML 3524
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 22922883
SIC: 2834 Pharmaceutical Preparations